Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 58.10
+0.70 (1.22%)
Oct 28, 2026, 4:00 PM EDT
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 27.03 billion as of October 28, 2026. It is the 4,190th most valuable company in the world and the 578th biggest in China. Its market cap has decreased by 4.22% in one year.
Market Cap
27.03B
Enterprise Value
26.64B
Revenue
968.83M
Global Rank
Country Rank
#578 China
PE Ratio
n/a
ChartMarket Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 27.03B, an increase of 64.39%. That is a compound annual growth rate of 10.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 27.03B | 1.74% |
| Dec 31, 2025 | 26.56B | 54.11% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
| Dec 10, 2021 | 16.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Tongrentang | 34.27B |
| Shenzhen Salubris Pharmaceuticals | 33.96B |
| Humanwell Healthcare (Group) | 32.14B |
| Dong-E-E-Jiao | 30.88B |
| Changchun High-Tech Industry (Group) | 29.51B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 27.23B |
| Shijiazhuang Yiling Pharmaceutical | 26.50B |
| Zhejiang Huahai Pharmaceutical | 24.93B |